AGA Nanotech News

Stay up to date with the latest news from AGA Nanotech

AGA Nanotech Joins HTCC Accelerator Programme

AGA Nanotech is excited to announce our selection for the Healthcare Technologies Capabilities Connector (HTCC) SME Accelerator Programme

AGA Nanotech Awarded Best Pitch at SBC Catalyser Programme 2024

AGA Nanotech has been awarded the SBC Catalyser 2024 Award for Battlestars application in wound care. This recognition highlights our commitment to advancing infection prevention technologies.

AGA Nanotech Chosen for Prestigious Innovate UK Microbials Accelerator

AGA Nanotech is proud to announce its selection for the highly competitive Innovate UK Microbials Accelerator Programme.

AGA Nanotech Secures Major Investment to Form AGA2Tech and Combat Antimicrobial Resistance in Livestock

AGA2tech, a new venture aimed at reducing antimicrobial resistance (AMR) in livestock farming.

Combining Cold Plasma and Acetyl Donor Molecules to Fight Diabetic Foot Ulcers and Airborne Viruses

AGA Nanotech is excited to announce a groundbreaking collaboration with the University of South Australia and Lancaster University.

AGA Nanotech Awarded £1 Million UK-China Collaboration to Tackle Antimicrobial Resistance

AGA Nanotech has been awarded £1 million in funding as part of a UK-China collaboration to develop new treatments aimed at controlling the spread of antibiotic-resistant pathogens in poultry.

AGA Nanotech and UCL Business Reach Milestone Licensing Agreement for TIPS Microparticle Technology

AGA Nanotech Ltd is pleased to announce the successful conclusion of a licensing agreement with UCL Business.